ADS

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, November 7, 2022
Warner, Turnaround ADR, Section 11 of the Canadian Charter of Rights and Freedoms, Battle of Saint-Fulgent, HBO Max, Anti-Kickback Statute, ADR, Annual report, U.S. Securities and Exchange Commission, AT, U.S. Department of Defense Strategy for Operating in Cyberspace, SEC, Health, Genetic testing, Disclosure, Company, Prospectus, Medicare, AT&T, GLOBE, Mergers and acquisitions, NYSE, Reward, IPO, Securities Act of 1933, Mission statement, U.S. Department of Justice Office of Legislative Affairs, Stark Law, Remuneration, Patient, Genetics, Complaint, YSG, Sale, HBO, COVID-19, Physician, Defendant, ADS, Justice, Investment, Federal, BCS, NASDAQ, Warner Bros., News, Register, Pharmaceutical industry, Music, Audit, Security (finance), WarnerMedia, Discovery, Barclays, P.C

Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.

Key Points: 
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • For more information on the Warner Bros. class action go to: https://bespc.com/cases/WBD
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

FDCTech's Quarterly Release for the Third Quarter (FY22 Q3) Results

Retrieved on: 
Friday, November 4, 2022
FDC, Company, LLC, Education, CA, CMAS, GLOBE, Letter, Hand, FINRA, Ownership, The Company, CIM, ADS, AD, CMA, Technology, SIPC, SEC, Solution, Security (finance)

During the nine months ended September 30, 2022, and 2021, the Company incurred a net loss of $1,002,849 and $977,933.

Key Points: 
  • During the nine months ended September 30, 2022, and 2021, the Company incurred a net loss of $1,002,849 and $977,933.
  • The cash on hand was $246,064 as of September 30, 2022, compared to $93,546 on December 31, 2021.
  • On September 30, 2022, the total stockholders' equity was $1,283,751 compared with a total stockholders' equity of $1,625,448 on December 31, 2021.
  • Please visit our SEC filings or Company's website for more information on the full results and management's plan.

Centessa Class Action Deadline Alert: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their CNTA Losses

Retrieved on: 
Friday, November 4, 2022
SAN, GLOBE, LLP, IPO, CNTA, ADS, Defendant, NASDAQ, Court, Class, Learning, Security (finance), Tobacco

SAN DIEGO, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Centessa Pharmaceuticals plc (Centessa or the Company) (NASDAQ: CNTA).

Key Points: 
  • SAN DIEGO, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Centessa Pharmaceuticals plc (Centessa or the Company) (NASDAQ: CNTA).
  • Investors are hereby notified that they have until November 28, 2022 to move the Court to serve as lead plaintiff in this action.
  • An investor's ability to share any potential future recovery of the Centessa class action lawsuit is not dependent upon serving as lead plaintiff.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia.

FDCTech's Quarterly Release for the Third Quarter (FY22 Q3) Results

Retrieved on: 
Friday, November 4, 2022
FDC, Company, LLC, Education, CMAS, GLOBE, Letter, Hand, FINRA, Ownership, The Company, CIM, ADS, AD, CMA, Technology, SIPC, SEC, Solution, Security (finance)

Irvine, CA:, Nov. 04, 2022 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," OTCQB: FDCT), a fintech-driven company specializing in buying and integrating small to mid-size legacy financial services companies, today announced the following results for the quarter ended September 30, 2022, as compared to the corresponding period of last fiscal year:

Key Points: 
  • During the nine months ended September 30, 2022, and 2021, the Company incurred a net loss of $1,002,849 and $977,933.
  • The net loss as a percentage of revenue decreased from 442.50% to 21.81% for the nine months ended September 30, 2022, compared to the previous period.
  • The cash on hand was $246,064 as of September 30, 2022, compared to $93,546 on December 31, 2021.
  • Please visit our SEC filings or Company's website for more information on the full results and management's plan.

O2Micro Reports Third Quarter 2022 Financial Results

Retrieved on: 
Friday, November 4, 2022
Consumer, Company, Intelligent lighting, Private Securities Litigation Reform Act, Investment, Corporation, GAAP, SEC filing, Risk, Battery management system, Annual Filing Season Program, International (Amtrak train), Battery, Marketing, CEO, US, Automotive industry, ADS, NASDAQ, Form, Technology, Computer, SEC, Terrorism, Solution, Video game, Renewable energy, Risk management

O2Micro expects the fourth quarter 2022 revenue to be in the range of $16.0 million to $19.0 million.

Key Points: 
  • O2Micro expects the fourth quarter 2022 revenue to be in the range of $16.0 million to $19.0 million.
  • O2Micro International Limited (NASDAQ: OIIM)(O2Micro), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, reported its financial results today for the third quarter ending September 30, 2022.
  • Financial Highlights for the Third Quarter ending September 30, 2022:
    O2Micro reported the third quarter 2022 revenue of $18.2 million within the guidance announced on July 29, 2022.
  • The gross margin in the third quarter of 2022 was 52.3%, which was up from 52.0% in the same quarter of 2021.

Hepsiburada Receives Nasdaq Notification Regarding Minimum Bid Price Requirement

Retrieved on: 
Friday, November 4, 2022
Empowerment, Company, Compliance, HEPS, Nasdaq, ADSS, Electronics manufacturing services, GLOBE, Woman, Listing Rules, Notice, Commerce, ADS, NASDAQ, Technology, Calendar, Female, Auction

ISTANBUL, Nov. 04, 2022 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services & Trading (d/b/a Hepsiburada) (NASDAQ: HEPS), a leading Turkish e-commerce platform (referred to herein as Hepsiburada or the Company), announces that on November 3, 2022 it received a written notice (the Notice) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) indicating that the bid price for the Companys American depositary shares (ADSs), each representing one Class B ordinary share of the Company, had closed below the minimum bid price requirement (Minimum Bid Requirement) of US$1.00 per share under the Nasdaq Listing Rules (the Listing Rules).

Key Points: 
  • ISTANBUL, Nov. 04, 2022 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services & Trading (d/b/a Hepsiburada) (NASDAQ: HEPS), a leading Turkish e-commerce platform (referred to herein as Hepsiburada or the Company), announces that on November 3, 2022 it received a written notice (the Notice) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) indicating that the bid price for the Companys American depositary shares (ADSs), each representing one Class B ordinary share of the Company, had closed below the minimum bid price requirement (Minimum Bid Requirement) of US$1.00 per share under the Nasdaq Listing Rules (the Listing Rules).
  • Based on the closing bid price of the Companys ADSs for the last 30 consecutive business days, the Company has failed to meet the Minimum Bid Requirement for continued listing on the Nasdaq Global Select Market set forth in Listing Rule 5450(a)(1) during that period.
  • The Company may regain compliance with the Minimum Bid Requirement if at any time before May 2, 2023, the bid price of the ADSs closes at or above US$1.00 per ADS for a minimum of 10 consecutive business days.
  • The Company will consider any measures necessary in order to regain compliance with the Minimum Bid Requirement.

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Yatsen Holding Limited Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – YSG

Retrieved on: 
Thursday, November 3, 2022
Titan, I-Space (Chinese company), YSG, Prospectus, NYSE, Advertising, IPO, ADS, Court, Insurance, Tobacco, Security (finance)

WHAT TO DO NEXT: To join the Yatsen class action, go to https://rosenlegal.com/submit-form/?case_id=8895 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Yatsen class action, go to https://rosenlegal.com/submit-form/?case_id=8895 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Retrieved on: 
Thursday, November 3, 2022
LR, Company, Protein, Allosteric regulation, Glutamate receptor, Compliance, GABAB, SIX Swiss Exchange, ADSS, ADX71149, Glutamate (neurotransmitter), Glutamic acid, Therapy, Janssen Pharmaceuticals, Epilepsy, Psychosis, US, Clinical trial, Depression, ADS, NAM, American depositary receipt, Calendar, Drug discovery, American, Pain, PAM, Pharmaceutical industry, Auction, Nasdaq

53 LR

Key Points: 
  • 53 LR
    Geneva, Switzerland, November 3, 2022 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development (the Company), announced today that it had received written notification from Nasdaq indicating that, for the last thirty consecutive business days, the bid price for the Companys American Depositary Shares (ADSs) had closed below the minimum US$1.00 per ADS requirement for continued listing on Nasdaq under listing rule 5550(a)(2).
  • Compliance will be achieved if the bid price of the ADSs closes at US$1.00 per ADS or more for a minimum of ten consecutive business days.
  • The Company will monitor the bid price of its ADSs and evaluate options to regain compliance with Nasdaqs minimum bid price rule within the compliance period.
  • The Companys operations are not affected by the receipt of the notification letter and The Company fully intends to resolve the deficiency and regain compliance with the Nasdaq Listing Rules.

OneConnect Announces Receipt of Notice Regarding NYSE Continued Listing Standards

Retrieved on: 
Thursday, November 3, 2022
Fintech, Other Professional Services, Professional Services, Finance, Company, Cure, Compliance, ADSS, Industry, COVID, Letter, U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, Ping An Insurance, NYSE, GM Gamma platform, Securities Exchange Act of 1934, Efficiency, Terminology, COVID-19, New, Forward-looking statement, ADS, Acquisition, Technology, Calendar, OneConnect Financial Technology, SEC, Solution, Cryptocurrency, Risk management, PRC

The notice has no immediate impact on the listing of the Companys ADSs, which will continue to be listed and traded on the NYSE, subject to the Companys compliance with other NYSE continued listing standards and other rights of the NYSE to delist the ADSs.

Key Points: 
  • The notice has no immediate impact on the listing of the Companys ADSs, which will continue to be listed and traded on the NYSE, subject to the Companys compliance with other NYSE continued listing standards and other rights of the NYSE to delist the ADSs.
  • The NYSE notification does not affect the Companys business operations, its U.S. Securities and Exchange Commission reporting requirements or contractual obligations.
  • The Company has six months (the Cure Period) following receipt of the notice to regain compliance with the minimum share price requirement.
  • OneConnect Financial Technology Co. Ltd. is a technology-as-a-service provider for the financial services industry in China with an expanding international presence.

Advanced Drainage Systems Announces Quarterly Cash Dividend

Retrieved on: 
Thursday, November 3, 2022
Manufacturing, Construction & Property, Other Natural Resources, Building Systems, Agriculture, Recycling, Natural Resources, Other Manufacturing, Environment, Engineering, Other Construction & Property, WMS, Advanced Drainage Systems, Company, Pandemic, Time, Drainage, Board, Solution, NYSE, COVID-19, Weather, Borrowing base, Plant, ADS, Risk, Board of directors, Agriculture, SEC, Water, Holding company, Risk management

Advanced Drainage Systems, Inc. (NYSE: WMS) (ADS or the Company), a leading provider of innovative water management solutions in the stormwater and on-site septic waste water industries, today announced that its Board of Directors (the Board) has approved a quarterly cash dividend to its shareholders in the amount of $0.12 per share, a 9% increase over the prior year dividend amount.

Key Points: 
  • Advanced Drainage Systems, Inc. (NYSE: WMS) (ADS or the Company), a leading provider of innovative water management solutions in the stormwater and on-site septic waste water industries, today announced that its Board of Directors (the Board) has approved a quarterly cash dividend to its shareholders in the amount of $0.12 per share, a 9% increase over the prior year dividend amount.
  • Scott Barbour, President and Chief Executive Officer of Advanced Drainage Systems commented, Todays dividend announcement is predicated on the strength of our balance sheet, formidable cash generation, and ongoing commitment to returning capital to shareholders.
  • The quarterly cash dividend of $0.12 per share will be paid on December 15, 2022, to shareholders of record at the close of business on December 1, 2022.
  • Advanced Drainage Systems is a leading manufacturer of innovative stormwater and onsite septic wastewater solutions that manages the worlds most precious resource: water.